- Adjunct Professor, Global Health
- Professor, Chemistry
Department of Chemistry, UW
Seattle, WA 98195
Select from the following:
Pradip Rathod is a Professor of Chemistry and an Adjunct Professor of Global Health at the University of Washington. He has over 35 years of experience in malaria Research, first starting with development of nanomolar-level selective inhibitors against parasites, then understanding mechanisms of parasite evolution, and now looking at all aspects of malaria in India (Drug resistance, Pathogenesis, Transmission, Genomics, and Epidemiology).
- PhD (Oregon Health & Science University)
- Community-Based Participatory Research
- Drug and Vaccine Development
- Host-Pathogen Interactions
- Infectious Diseases
- Pharmaceutical Science
Demographic and clinical profiles of Plasmodium falciparum and Plasmodium vivax patients at a tertiary care centre in southwestern India. Chery L, Maki JN, Mascarenhas A, Walke JT, Gawas P, Almeida A, Fernandes M, Vaz M, Ramanan R, Shirodkar D, Bernabeu M, Manoharan SK, Pereira L, Dash R, Sharma A, Shaik RB, Chakrabarti R, Babar P, White J 3rd, Mudeppa DG, Kumar S, Zuo W, Skillman KM, Kanjee U, Lim C, Shaw-Saliba K, Kumar A, Valecha N, Jindal VN, Khandeparkar A, Naik P, Amonkar S, Duraisingh MT, Tuljapurkar S, Smith JD, Dubhashi N, Pinto RG, Silveria M, Gomes E, Rathod PK.
Malar J. 2016 Nov 25;15(1):569. PMID: 27884146
Distinct genomic architecture of Plasmodium falciparum populations from South Asia. Kumar S, Mudeppa DG, Sharma A, Mascarenhas A, Dash R, Pereira L, Shaik RB, Maki JN, White J 3rd, Zuo W, Tuljapurkar S, Duraisingh MT, Gomes E, Chery L, Rathod PK. Mol Biochem Parasitol. 2016 Nov - Dec;210(1-2):1-4. PMID: 27457272
Severe adult malaria is associated with specific PfEMP1 adhesion types and high parasite biomass. Bernabeu M, Danziger SA, Avril M, Vaz M, Babar PH, Brazier AJ, Herricks T, Maki JN, Pereira L, Mascarenhas A, Gomes E, Chery L, Aitchison JD, Rathod PK, Smith JD. Proc Natl Acad Sci U S A. 2016; 113(23):E3270-9.
A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria.
Phillips MA, Lotharius J, Marsh K, White J, Dayan A, White KL, Njoroge JW, El Mazouni F, Lao Y, Kokkonda S, Tomchick DR, Deng X, Laird T, Bhatia SN, March S, Ng CL, Fidock DA, Wittlin S, Lafuente-Monasterio M, Benito FJ, Alonso LM, Martinez MS, Jimenez-Diaz MB, Bazaga SF, Angulo-Barturen I, Haselden JN, Louttit J, Cui Y, Sridhar A, Zeeman AM, Kocken C, Sauerwein R, Dechering K, Avery VM, Duffy S, Delves M, Sinden R, Ruecker A, Wickham KS, Rochford R, Gahagen J, Iyer L, Riccio E, Mirsalis J, Bathhurst I, Rueckle T, Ding X, Campo B, Leroy D, Rogers MJ, Rathod PK, Burrows JN, Charman SA. Sci Transl Med. 2015;7(296):296
Asexual populations of the human malaria parasite, Plasmodium falciparum, use a two-step genomic strategy to acquire accurate, beneficial DNA amplifications.
Guler JL, Freeman DL, Ahyong V, Patrapuvich R, White J, Gujjar R, Phillips MA, DeRisi J, Rathod PK.
PLoS Pathog. 2013;9(5):e1003375.